| 期刊論文1. | Robinson, N.、Saugy, M.、Vernec, A.、Pierre-Edouard, S.(2011)。The athlete biological passport: An effective tool in the fight against doping。Clinical Chemistry,57(6),830-832。 | 2. | Sottas, Pierre-Edouard、Robinson, Neil、Rabin, Oliver、Saugy, Martial(2011)。The Athlete Biological Passport。Clinical Chemistry,57(7),969-976。 | 3. | 方世華(20140900)。從基因治療到基因禁藥。運動教練科學,35,1-16。 延伸查詢 | 4. | Brittberg, M.、Lindahl, A.、Nilsson, A.、Ohlsson, C.、Isaksson, O.、Peterson, L.(1994)。Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation。The New England Journal of Medicine,331(14),889-895。 | 5. | Bryant, L. M.、Christopher, D. M.、Giles, A. R.、Hinderer, C.、Rodriguez, J. L.、Smith, J. B.、Wilson, J. M.(2013)。Lessons learned from the clinical development and market authorization of Glybera。Human Gene Therapy Clinical Development,24(2),55-64。 | 6. | Connor, J.、Woolf, J.、Mazanov, J.(2013)。Would they dope? Revisiting the goldman dilemma。British Journal of Sports Medicine,47(11),697-700。 | 7. | Davies, R. L.、Kuiper, N. J.(2019)。Regenerative medicine: A review of the evolution of autologous chondrocyte implantation (ACI) therapy。Bioengineering,6(1)。 | 8. | De la Garza-Rodea, A. S.、Van der Velde-van Dijke, I.、Boersma, H.、Goncalves, M. A.、Van Bekkum, D. W.、De Vries, A. A.、Knaan-Shanzer, S.(2012)。Myogenic properties of human mesenchymal stem cells derived from three different sources。Cell Transplantion,21(1),153-173。 | 9. | Ehlert, T.、Simon, P.、Moser, D. A.(2013)。Epigenetics in sports。Sports Medicine,43(2),93-110。 | 10. | Friedmann, T.、Koss, J. O.(2001)。Gene transfer and athletics-An impending problem。Molecular Therapy,3(6),819-820。 | 11. | Goodwin, Sara、McPherson, John D.、McCombie, W. Richard(2016)。Coming of age: Ten years of next-generation sequencing technologies。Nature Reviews Genetics,17(6),333-351。 | 12. | Holzinger, A.、Barden, M.、Abken, H.(2016)。The growing world of CAR T cell trials: A systematic review。Cancer Immunology Immunotherapy,65(12),1433-1450。 | 13. | Locke, A. E.、Kahali, B.、Berndt, S. I.、Justice, A. E.、Pers, T. H.、Day, F. R.、Speliotes, E. K.(2015)。Genetic studies of body mass index yield new insights for obesity biology。Nature,518(7538),197-206。 | 14. | Mattsson, C. M.、Wheeler, M. T.、Waggott, D.、Caleshu, C.、Ashley, E. A.(2016)。Sports genetics moving forward: Lessons learned from medical research。Physiological Genomics,48(3),175-182。 | 15. | Mendell, J. R.、Sahenk, Z.、Malik, V.、Gomez, A. M.、Flanigan, K. M.、Lowes, L. P.、Kaspar, B. K.(2015)。A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy。Molecular Therapy,23(1),192-201。 | 16. | Mobasheri, A.、Kalamegam, G.、Musumeci, G.、Batt, M. E.(2014)。Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions。Maturitas,78(3),188-198。 | 17. | Montgomery, H. E.、Marshall, R.、Hemingway, H.、Myerson, S.、Clarkson, P.、Dollery, C.、Humphries, S. E.(1998)。Human gene for physical performance。Nature,393(6682),221-222。 | 18. | Mulcahy, L. A.、Pink, R. C.、Carter, D. R.(2014)。Routes and mechanisms of extracellular vesicle uptake。Journal of Extracellular Vesicles,3。 | 19. | Mullard, A.(2016)。EMA greenlights second gene therapy。Nature Reviews. Drug Discovery,15(5)。 | 20. | Neuberger, E. W. I.、Simon, P.(2017)。Gene and cell doping: The new frontier-beyond myth or reality。Medicine and Sport Science,62,91-106。 | 21. | Osborne, H.、Anderson, L.、Burt, P.、Young, M.、Gerrard, D.(2016)。Australasian College of Sports Physicians-position statement: The place of mesenchymal stem/stromal cell therapies in sport and exercise medicine。British Journal of Sports Medicine,50(20),1237-1244。 | 22. | Pas, H.、Moen, M. H.、Haisma, H. J.、Winters, M.(2017)。No evidence for the use of stem cell therapy for tendon disorders: A systematic review。British Journal of Sports Medicine,51(13),996-1002。 | 23. | Pitsiladis, Y. P.、Durussel, J.、Rabin, O.(2014)。An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping。British Journal of Sports Medicine,48(10),856-861。 | 24. | Pittenger, M. F.、Mackay, A. M.、Beck, S. C.、Jaiswal, R. K.、Douglas, R.、Mosca, J. D.、Marshak, D. R.(1999)。Multilineage potential of adult human mesenchymal stem cells。Science,284(5411),143-147。 | 25. | Rankinen, Tuomo、Fuku, N.、Wolfarth, B.、Wang, G.、Sarzynski, M. A.、Alexeev, D. G.、Bouchard, C.(2016)。No evidence of a common DNA variant profile specific to world class endurance athletes。PLoS One,11(1)。 | 26. | Thompson, H.(2012)。Performance enhancement: Superhuman athletes。Nature,487(7407),287-289。 | 27. | Trounson, A.、McDonald, C.(2015)。Stem cell therapies in clinical trials: Progress and challenges。Cell Stem Cell,17(1),11-22。 | 28. | Uccelli, A.、Moretta, L.、Pistoia, V.(2008)。Mesenchymal stem cells in health and disease。Nature Reviews. Immunology,8(9)。 | 29. | Valadi, H.、Ekstrom, K.、Bossios, A.、Sjostrand, M.、Lee, J. J.、Lotvall, J. O.(2007)。Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells。Nature Cell Biology,9(6),654-659。 | 30. | Varlet-Marie, E.、Audran, M.、Ashenden, M.、Sicart, M. T.、Piquemal, D.(2009)。Modification of gene expression: Help to detect doping with erythropoiesis-stimulating agents。American Journal of Hematology,84(11),755-759。 | 31. | Wang, J.、Sun, X.、Zhao, J.、Yang, Y.、Cai, X.、Xu, J.、Cao, P.(2017)。Exosomes: A novel strategy for treatment and prevention of diseases。Frontiers Pharmacology,8,300-327。 | 32. | Wood, A. R.、Esko, T.、Yang, J.、Vedantam, S.、Pers, T. H.、Gustafsson, S.、Frayling, T. M.(2014)。Defining the role of common variation in the genomic and biological architecture of adult human height。Nature Genetics,46(11),1173-1186。 | 33. | Xu, L.、Li, G.(2014)。Circulating mesenchymal stem cells and their clinical implications。Journal of Orthopaedic Translation,2(1),1-7。 | 34. | Yamamoto, S.、Azuma, E.、Muramatsu, M.、Hamashima, T.、Ishii, Y.、Sasahara, M.(2016)。Significance of extracellular vesicles: Pathobiological roles in disease。Cell Structure and Function,41(2),137-143。 | 35. | Yong, S. B.、Chung, J. Y.、Song, Y.、Kim, Y. H.(2018)。Recent challenges and advances in genetically-engineered cell therapy。Journal of Pharmaceutical Investigation,48(2),199-208。 | 36. | Zorzoli, M.、Pipe, A.、Garnier, P. Y.、Vouillamoz, M.、Dvorak, J.(2014)。Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming。British Journal of Sports Medicine,48(10),862-866。 | 圖書1. | Minas, T.(2011)。A primer in cartilage repair and joint preservation of the knee e-Book: Expert consult。Elsevier Health Sciences。 | 其他1. | Veritas Genetics(20150929)。Veritas genetics breaks 1,000 whole genome barrier,https://futurism.com/veritas-genetics-and-george-church-break-the-1000-whole-genome-barrier。 | 2. | Veritas Genetics(2016)。Veritas genetics launches 9 whole genome and sets new standard for genetic testing,https://www.prnewswire.com/news-releases/veritas-genetics-launches-999-whole-genome-and-sets-new-standard-for-genetic-testing-300230258.html。 | 3. | World Anti-Doping Agency(20190101)。WADA publishes 2019 prohibited list,https://www.wada-World Anti-Doping Agencyama.org/sites/default/files/wada_2019_english_prohibited_list.pdf。 | 4. | World Health Organization(2017)。Haematopoietic Stem Cell Transplantation HSCtx,http://www.who.int/transplantation/hsctx/en/。 | 圖書論文1. | Rahim, S.、Rahim, F.、Shirbandi, K.、Haghighi, B. B.、Arjmand, B.(2018)。Sports injuries: Diagnosis, prevention, stem cell therapy, and medical sport strategy。Tissue Engineering and Regenerative Medicine。New York:Springer。 | |